Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

Alice Carrier

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6599-9642; OpenAlex author ID A5040914639. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
30
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 10

  1. Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer. Last author DOI 10.1038/s41389-025-00591-0↗
  2. Integrative study of skeletal muscle mitochondrial dysfunction in a murine pancreatic cancer-induced cachexia model. Last author DOI 10.7554/elife.93312↗
  3. Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo. Last author DOI 10.1016/j.isci.2023.106899↗
  4. Pesticides and pancreatic adenocarcinoma: A transversal epidemiological, environmental and mechanistic narrative review. Co-author DOI 10.1016/j.dld.2022.08.023↗
  5. Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. Co-author DOI 10.15252/emmm.202013502↗
  6. Targeting Redox Metabolism in Pancreatic Cancer. Last author DOI 10.3390/ijms22041534↗
  7. Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer. Last author DOI 10.1016/j.xcrm.2020.100143↗
  8. Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies. Last author DOI 10.3390/biomedicines8080270↗
  9. PML hyposumoylation is responsible for the resistance of pancreatic cancer. Co-author DOI 10.1096/fj.201901091r↗
  10. TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression. Co-author DOI 10.1038/onc.2011.25↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gabriela Reyes‐Castellanos · 8 shared papers, 2020–2025 · strength 1.40
  2. Rawand Masoud · 5 shared papers, 2019–2025 · strength 0.75
  3. Tristan Gicquel · 4 shared papers, 2020–2025 · strength 0.71
  4. Nadine Abdel Hadi · 4 shared papers, 2020–2025 · strength 0.71
  5. Juan Iovanna · 5 shared papers, 2011–2025 · strength 0.58
  6. Nelson Dusetti · 4 shared papers, 2011–2023 · strength 0.34
  7. Odile Gayet · 3 shared papers, 2019–2023 · strength 0.32
  8. Abdessamad El Kaoutari · 2 shared papers, 2020–2023 · strength 0.24
  9. Mathias Brügel · 1 shared paper, 2022 · strength 0.19
  10. Olivier Bouché · 1 shared paper, 2022 · strength 0.19
  11. Fabienne Guillaumond · 1 shared paper, 2023 · strength 0.15
  12. Fabrice Muscari · 1 shared paper, 2021 · strength 0.09
  13. Célia Cintas · 1 shared paper, 2021 · strength 0.09
  14. Chiara Falcomatà · 1 shared paper, 2021 · strength 0.09
  15. Coralie Cayron · 1 shared paper, 2021 · strength 0.09
  16. Céline Basset · 1 shared paper, 2021 · strength 0.09
  17. Romain Baer · 1 shared paper, 2021 · strength 0.09
  18. Benoît Thibault · 1 shared paper, 2021 · strength 0.09
  19. Nicole Therville · 1 shared paper, 2021 · strength 0.09
  20. Julie Guillermet‐Guibert · 1 shared paper, 2021 · strength 0.09
  21. Pierre Cordelier · 1 shared paper, 2021 · strength 0.09
  22. Barbara Bournet · 1 shared paper, 2021 · strength 0.09
  23. Dieter Saur · 1 shared paper, 2021 · strength 0.09
  24. Mirna Swayden · 1 shared paper, 2019 · strength 0.08
  25. Julie Roques · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.